0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      The Hypothalamus Is not the Origin of Vasopressin and Oxytocin in the Rat Pineal Gland

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Immunoreactive levels of vasopressin (VP) and oxytocin (OT) were quantitated in the rat pineal gland in the middle of August, when nonapeptide levels have been reported to peak annually. The pineal levels of both VP and OT were found to be substantially elevated when sampled in August, compared to sampling in July and September. mRNA levels for OT and VP in hypothalamic nuclei (supraoptic, paraventricular, and suprachiasmatic nuclei) showed no such increases during August. A lesioning of the paraventricular nuclei did not suppress pineal VP and OT levels. Finally, the injection of colchicine into the third ventricle caused pineal VP and OT levels to increase substantially. Together, these results affirm the occurence of a summertime rise in pineal VP and OT levels and suggest that such increases do not derive from sites of VP and OT cell bodies in the hypothalamus. Rather, they indicate that the source of these pineal nonapeptides may be the pineal itself.

          Related collections

          Author and article information

          Journal
          NEN
          Neuroendocrinology
          10.1159/issn.0028-3835
          Neuroendocrinology
          S. Karger AG
          0028-3835
          1423-0194
          1991
          1991
          04 April 2008
          : 53
          : 5
          : 523-527
          Affiliations
          aRudolf Magnus Institute, Medical Faculty, University of Utrecht, The Netherlands; bNeuroendocrine Program, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pa., USA; cDepartment of Human Anatomy, Oxford University, UK
          Article
          125767 Neuroendocrinology 1991;53:523–527
          10.1159/000125767
          1870665
          © 1991 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 5
          Categories
          Original Paper

          Comments

          Comment on this article